Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis J Aronne

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Gastroenterology & Hepatology|March 21, 2017
Weight-Reduction Counseling in Gastroenterologic and Hepatologic PracticeLouis J Aronne
Obesity Research|December 20, 2002
Obesity as a disease: etiology, treatment, and management considerations for the obese patientLouis J Aronne
Obesity Research|December 20, 2002
Classification of obesity and assessment of obesity-related health risksLouis J Aronne
JAAPA : Official Journal of the American Academy of Physician Assistants|December 1, 2007
The impact of obesity on cardiometabolic riskLouis J Aronne
Nature Clinical Practice. Endocrinology & Metabolism|March 16, 2007
Is rimonabant a safe and effective treatment for obesity?Louis J Aronne
The American Journal of Medicine|February 27, 2007
Therapeutic options for modifying cardiometabolic risk factorsLouis J Aronne
The Journal of Family Practice|September 9, 2014
Evolving directions in obesity managementLouis J Aronne
The New England Journal of Medicine|October 22, 2025
Tirzepatide vs. Semaglutide for Obesity Treatment. ReplyLouis J Aronne
JAMA|April 17, 2024
Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity-ReplyLouis J Aronne,
Obesity (Silver Spring, Md.)|March 26, 2018
ADOPT: Obesity Treatment Reaches Level of Maturity with Its Own Collaborative Initiative and ResourceWanda Truong, Louis J Aronne
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Gastroenterology & Hepatology|March 21, 2017
Weight-Reduction Counseling in Gastroenterologic and Hepatologic PracticeLouis J Aronne
Obesity Research|December 20, 2002
Obesity as a disease: etiology, treatment, and management considerations for the obese patientLouis J Aronne
Obesity Research|December 20, 2002
Classification of obesity and assessment of obesity-related health risksLouis J Aronne
JAAPA : Official Journal of the American Academy of Physician Assistants|December 1, 2007
The impact of obesity on cardiometabolic riskLouis J Aronne
Nature Clinical Practice. Endocrinology & Metabolism|March 16, 2007
Is rimonabant a safe and effective treatment for obesity?Louis J Aronne
The American Journal of Medicine|February 27, 2007
Therapeutic options for modifying cardiometabolic risk factorsLouis J Aronne
The Journal of Family Practice|September 9, 2014
Evolving directions in obesity managementLouis J Aronne
The New England Journal of Medicine|October 22, 2025
Tirzepatide vs. Semaglutide for Obesity Treatment. ReplyLouis J Aronne
JAMA|April 17, 2024
Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity-ReplyLouis J Aronne,
Obesity (Silver Spring, Md.)|March 26, 2018
ADOPT: Obesity Treatment Reaches Level of Maturity with Its Own Collaborative Initiative and ResourceWanda Truong, Louis J Aronne
Pageof 17